During Brazil's COVID-19 vaccination campaign, when several brands of vaccines were available and the Chinese vaccine was the most common, an unprecedented phenomenon occurred. People crossed ...

Trump has doubled tariffs on Indian imports to 50 per cent, citing New Delhi’s ongoing trade ties with Russia. The move came ...

AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump pressures ...

U.K.-based drug giant AstraZeneca will make what it calls its single-largest manufacturing investment in the world with a new facility in Virginia.

AstraZeneca said Tuesday it's planning to invest $50 billion in expanding its manufacturing and research presence in the U.S. by 2030, as worries about tariffs loom over the industry.

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The proposed site was not disclosed.

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to ...

What happened to mandatory country of origin meat labeling in the new Farm Bill?..oops there is no new Farm Bill. I guess when small and mid-size farmers are gone you and the former governor can ...

Pharma AstraZeneca, facing lung cancer challenge from J&J, touts life-extension benefit for Tagrisso combo By Angus Liu Jul 21, 2025 2:59pm AstraZeneca Tagrisso EGFR-mutated lung cancer Johnson ...

AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca has announced a new clinical study titled ‘Exacerbations and Their Outcomes in Egyptian Patients (EXACOS EG Population),’ which aims to explore the burden of severe exacerbations ...